Vir Share Price

Vir Share Price

NASDAQ: VIR | Small Cap | Healthcare
$8.38
-$0.51 (-5.74%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Vir Stock Performance

Open
$8.75
Prev. Close
$8.88
Circuit Range
N/A
Day Range
$8.35 - $8.91
Year Range
$5.46 - $14.34
Volume
1,63,297
Average Traded
$8.55

Vir Share Price Today

As of 22 November 2026, Vir Biotechnology, Inc.'s share price is $8.38. The stock opened at $8.75, compared to its previous close of $8.88. During today's trading session, Vir Biotechnology, Inc.'s share price traded between $8.35 and $8.91, with an average price of $8.63. Over the past 52 weeks, the stock has recorded a high of $14.34 and a low of $5.46. In terms of performance, Vir Biotechnology, Inc.'s share price has declined by 12.12% over the last six months and is up 30.25% on a year-on-year basis.

Vir Share Price Chart

Line chart of the Vir price trend over the selected period. The price fell overall, ranging from 8.35 to 8.90, ending at 8.38.
$8.35$8.91
L
Show Current Price
H

Vir Stock Fundamentals & Key Indicators

Market Cap
$1.16B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.99
Revenue (TTM)
$68.56B
Return On Equity (TTM)
-20.62%
Profit Margin
-638.84%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-124.25%

Vir Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$64.07-$0.03$238.95-$0.19
Net Profit-$42.92-$125.70$80.08-$96.25
Net Profit Margin-66.99%419000.00%33.51%50657.89%
Income ChangeN/A-192.87%163.71%-220.19%

Vir Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1615.80$86.18$74.21$68.56
Net Profit$515.84-$615.06-$521.96-$437.99
Net Profit Margin31.92%-713.69%-703.36%-638.84%
Income ChangeN/A-219.23%15.14%16.09%

Vir Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets488.74356.36330.83283.01
Current Assets514.081042.461588.232519.08
Total Assets1002.821398.811919.062802.09
Non Current Liabilities144.73128.77153.42213.1
Current Liabilities92.82119.66175.41511.03
Total Liabilities237.55248.43328.82724.13
Shareholders' Equity765.281150.391590.242077.96

Vir Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-391.78-446.35-778.791,663.25
Investing310.37499.37164.63-1,193.46
Financing3.794.397.4834.76

About Vir

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Vir Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$11.46
$8.38
-25.85%
Oct 2026
$11.18
$11.29
+1.07%
Sep 2026
$10.88
$11.18
-1.24%
Aug 2026
$8.69
$11.31
+30.66%
Jul 2026
$10.27
$8.66
-14.89%
Jun 2026
$9.42
$10.18
+6.77%
May 2026
$10.20
$9.53
-6.71%
Apr 2026
$9.10
$10.21
+14.13%
Mar 2026
$8.91
$8.95
-1.54%
Feb 2026
$7.34
$9.09
+22.18%
Jan 2026
$6.01
$7.44
+23.59%
Dec 2025
$6.27
$6.02
-6.38%

Vir Share Price FAQs